DEEPAKNTR - Investment Analysis
Last Updated Time : 02 Aug 25, 12:58 am
Back to Investment ListInvestment Rating: 3.6
π§ͺ Fundamental Analysis: Deepak Nitrite Ltd. (DEEPAKNTR)
Deepak Nitrite is a specialty chemicals company with a strong track record in profitability and innovation. However, recent earnings stagnation and valuation concerns suggest a cautious approach for long-term investors.
Metric Value Implication
P/E Ratio 37.4 Slightly overvalued vs. industry PE of 34.4
PEG Ratio -2.71 Negative β indicates earnings contraction or volatility
ROCE / ROE 16.3% / 13.4% Decent β above average, but not exceptional
Dividend Yield 0.40% Low β not attractive for income investors
Debt-to-Equity 0.24 Low β financially sound
EPS βΉ51.1 Solid earnings base
Qtr Profit Var +3.35% Mild growth β not high momentum
FII/DII Holding Change +0.04% / -0.61% Mixed sentiment; DII reduction is a concern
π Technical Analysis
Current Price: βΉ1,865
DMA 50 / DMA 200: βΉ1,958 / βΉ2,155 β Trading below both; bearish trend
RSI: 31.5 β Near oversold zone; potential bounce
MACD: -20.8 β Bearish crossover; short-term weakness
Volume: Slightly above average β mild interest
π° Ideal Entry Price Zone
βΉ1,750ββΉ1,800
This range aligns with recent support and RSI oversold levels
Avoid entry above βΉ2,000 unless earnings growth resumes and PEG improves
π Long-Term Investment Outlook
Strengths
Strong brand in specialty chemicals
Low debt β robust balance sheet
Decent ROCE and ROE β efficient operations
EPS base supports valuation if growth returns
Risks
PEG < 0 β poor earnings visibility
P/E > industry average β valuation stretch
RSI and MACD suggest short-term weakness
DII selling β sentiment drag
Deepak Nitrite is a quality cyclical stock with long-term potential if earnings growth revives. Itβs suitable for investors who can tolerate volatility and are betting on specialty chemicals demand.
π Exit Strategy / Holding Period
If you already hold DEEPAKNTR
Holding Period: 2β3 years with close monitoring of quarterly results
Exit Strategy
Consider trimming near βΉ2,200ββΉ2,300 if valuation stretches without growth
Reassess if ROCE drops below 12% or PEG remains negative
Hold if earnings growth resumes and margins expand
Would you like a peer comparison with companies like Aarti Industries, Navin Fluorine, or Vinati Organics to explore better growth or valuation dynamics in specialty chemicals?
Edit in a page
Back to Investment List